BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22710427)

  • 1. Functional and phenotypical impairment of polymorphonuclear cells in atopic dermatitis: an additional cause for the known susceptibility to infections?
    Fierro MT; Banche G; Marenco F; Novelli M; Allizond V; Mandras N; Murabito P; Merlino C; Quaglino P; Bernengo MG; Cuffini AM
    Dermatology; 2012; 224(4):323-30. PubMed ID: 22710427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients.
    Fierro MT; Cuffini AM; Novelli M; Banche G; Allizond V; Comessatti A; Brizio M; Scalas D; Merlino C; Quaglino P; Bernengo MG
    Eur J Dermatol; 2011; 21(6):921-9. PubMed ID: 21951393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of components of the CD14/TLR system on leukocytes of patients with atopic dermatitis.
    Sümegi A; Szegedi A; Gál M; Hunyadi J; Szegedi G; Antal-Szalmás P
    Int Arch Allergy Immunol; 2007; 143(3):177-84. PubMed ID: 17284926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis.
    Hasannejad H; Takahashi R; Kimishima M; Hayakawa K; Shiohara T
    J Allergy Clin Immunol; 2007 Jul; 120(1):69-75. PubMed ID: 17531301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of age on neutrophil phagocytic reaction with different capsular serotypes of Klebsiella pneumoniae.
    Chiu CH; Yeh KM; Siu LK; Fung CP; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2011 Oct; 44(5):333-7. PubMed ID: 21524978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of antiserum and phagocytic cells in the protection of mice against infection by Klebsiella pneumoniae.
    Fukutome T; Mitsuyama M; Takeya K; Nomoto K
    J Gen Microbiol; 1980 Jul; 119(1):225-9. PubMed ID: 6997433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients.
    Cuffini AM; Tullio V; Giacchino F; Mandras N; Scalas D; Belardi P; Merlino C; Carlone NA
    Am J Kidney Dis; 2001 Jun; 37(6):1253-9. PubMed ID: 11382696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of phagocytes in atopic dermatitis.
    Forte WC; Guardian VC; Mantovani PA; Dionigi PC; Menezes MC
    Allergol Immunopathol (Madr); 2009; 37(6):302-8. PubMed ID: 19853354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing opsonizing and killing effect of serum from patients with recurrent K1 Klebsiella pneumoniae liver abscess.
    Yeh FC; Yeh KM; Siu LK; Fung CP; Yang YS; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2012 Apr; 45(2):141-6. PubMed ID: 22444545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atopic dermatitis: a disease caused by innate immune defects?
    De Benedetto A; Agnihothri R; McGirt LY; Bankova LG; Beck LA
    J Invest Dermatol; 2009 Jan; 129(1):14-30. PubMed ID: 19078985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of T-regulatory cells and Toll-like receptors 2 and 4 in atopic dermatitis.
    Lesiak A; Smolewski P; Sobolewska-Sztychny D; Sysa-Jedrzejowska A; Narbutt J
    Scand J Immunol; 2012 Oct; 76(4):405-10. PubMed ID: 22686584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
    Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
    Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis.
    Antiga E; Volpi W; Torchia D; Fabbri P; Caproni M
    Clin Exp Dermatol; 2011 Apr; 36(3):235-41. PubMed ID: 21070333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte toll-like receptor expression in end-stage kidney disease.
    Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired CD23 and CD62L expression and tissue inhibitors of metalloproteinases secretion by eosinophils in adults with atopic dermatitis.
    de Oliveira Titz T; Orfali RL; de Lollo C; Dos Santos VG; da Silva Duarte AJ; Sato MN; Aoki V
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2072-2076. PubMed ID: 27406841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE levels and PMN chemotaxis in atopic dermatitis.
    Galli E; Rossi P; Fiore L; Perlini R; Celiboni F; Betti P; Businco L
    Allergol Immunopathol (Madr); 1983; 11(3):189-94. PubMed ID: 6605080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis--measurement of lucigenin-dependent chemiluminescence.
    Kapp A; Schöpf E
    Acta Derm Venereol; 1986; 66(4):285-9. PubMed ID: 2430396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis.
    Oh DY; Schumann RR; Hamann L; Neumann K; Worm M; Heine G
    Allergy; 2009 Nov; 64(11):1608-15. PubMed ID: 19627277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immune defects in atopic dermatitis.
    McGirt LY; Beck LA
    J Allergy Clin Immunol; 2006 Jul; 118(1):202-8. PubMed ID: 16815156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microorganisms in atopic dermatitis.
    Baker BS
    Clin Exp Immunol; 2006 Apr; 144(1):1-9. PubMed ID: 16542358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.